Genoil (GNOLF) EBIAT (2020 - 2025)
Historic EBIAT for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to -$155119.0.
- Genoil's EBIAT fell 610.35% to -$155119.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 2941.13%. This contributed to the annual value of -$2.1 million for FY2024, which is 5177.62% up from last year.
- According to the latest figures from Q3 2025, Genoil's EBIAT is -$155119.0, which was down 610.35% from -$221743.0 recorded in Q2 2025.
- Over the past 5 years, Genoil's EBIAT peaked at $408992.0 during Q1 2021, and registered a low of -$2.5 million during Q1 2022.
- Its 5-year average for EBIAT is -$695123.9, with a median of -$427717.0 in 2022.
- In the last 5 years, Genoil's EBIAT plummeted by 71703.29% in 2022 and then soared by 9429.86% in 2024.
- Quarter analysis of 5 years shows Genoil's EBIAT stood at -$755601.0 in 2021, then plummeted by 55.34% to -$1.2 million in 2022, then changed by 0.0% to -$1.2 million in 2023, then plummeted by 36.93% to -$1.6 million in 2024, then soared by 90.35% to -$155119.0 in 2025.
- Its EBIAT was -$155119.0 in Q3 2025, compared to -$221743.0 in Q2 2025 and -$154992.0 in Q1 2025.